Evidence map›Paper›PMID 36376872›Full record

ArticleJournal of biomedical science2022

Hepatitis B virus suppresses complement C9 synthesis by limiting the availability of transcription factor USF-1 and inhibits formation of membrane attack complex: implications in disease pathogenesis.

Ayana Baidya, Mousumi Khatun, Rajiv Kumar Mondal, Suchandrima Ghosh, Bidhan Chandra Chakraborty, Shreya Mallik, S K Mahiuddin Ahammed, Abhijit Chowdhury, Soma Banerjee, Simanti Datta

Open access · diamondAbstract read
In one paragraph

Article in Journal of biomedical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Ayana BaidyaCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India.
Mousumi KhatunCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India.
Rajiv Kumar MondalCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India.
Suchandrima GhoshCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India.
Bidhan Chandra ChakrabortyMultidisciplinary Research Unit, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A. J. C. Bose Road, Kolkata, 700020, India.
Shreya MallikCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India.
S K Mahiuddin AhammedDepartment of Hepatology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A. J. C. Bose Road, Kolkata, 700020, India.
Abhijit ChowdhuryDepartment of Hepatology, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A. J. C. Bose Road, Kolkata, 700020, India.
Soma BanerjeeCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India.
Simanti DattaCentre for Liver Research, School of Digestive and Liver Diseases, Institute of Post Graduate Medical Education and Research (I.P.G.M.E.&R.), 244, A.J. C. Bose Road, Kolkata, 700020, India. seemdatt@gmail.com.
Institute of Post Graduate Medical Education and Research · IN

Funding

Indian Council of Medical Research 2019-6905/CMB/BMSIndian Council of Medical Research 3/1/3/JRF-2020/HRD-LS/133146/16Indian Council of Medical Research VIR/10/2020/ECD-1
6 · The paper itself

Abstract

backgroundThe complement system functions primarily as a first-line host defense against invading microbes, including viruses. However, the interaction of Hepatitis B virus (HBV) with the complement-components during chronic HBV infection remains largely unknown. We investigated the mechanism by which HBV inhibits the formation of cytolytic complement membrane-attack complex (MAC) and studied its impact on MAC-mediated microbicidal activity and disease pathogenesis.

methodsBlood/liver tissues were collected from chronically HBV-infected patients and controls. HepG2

resultsAmong the MAC components (C5b-C9), significant reduction was noted in the expression of C9, the major constituent of MAC, in HBV-infected HepG2

conclusionCollectively, HBX suppressed C9 transcription by restricting the availability of USF-1 through hypermethylation of USF-1-promoter and consequently hinder the formation and lytic functions of MAC. Early therapy is needed for both CHB and IT to normalize the aberrant complement profile and contain viral and bacterial infection and limit disease progression.

Indexed as

Hepatitis B, ChronicHepatitis B virusComplement C9Complement Membrane Attack ComplexDNA, BacterialEndotoxinsHep G2 CellsHumansTrans-ActivatorsUpstream Stimulatory FactorsViral Regulatory and Accessory ProteinsComplement C9Complement Membrane Attack ComplexDNA, BacterialEndotoxinsTrans-ActivatorsUpstream Stimulatory FactorsUSF1 protein, humanViral Regulatory and Accessory ProteinsComplement C9HBXMembrane attack complexPromoter hypermethylationUSF-1

Identifiers

PMID36376872
PMCPMC9664717
OpenAlexW4308948161

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.